◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
康华生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015
+Revenue 1.4B 1.6B 1.4B 1.3B 1.0B 555.0M 559.0M 262.0M 92.9M 71.1M
Revenue Growth % -9.2% 9.0% 12.0% 24.4% 87.2% -0.7% 113.4% 182.0% 30.7% --
Total Revenue 1.4B 1.6B 1.4B 1.3B 1.0B 555.0M 559.0M 262.0M 92.9M 71.1M
Cost Of Revenue 83.0M 103.0M 93.1M 83.8M 62.8M 32.3M 31.1M 27.6M 8.6M 11.1M
+Gross Profit 1.3B 1.5B 1.4B 1.2B 976.2M 522.7M 527.9M 234.4M 84.3M 60.0M
Gross Margin % 94.2% 93.5% 93.6% 93.5% 94.0% 94.2% 94.4% 89.5% 90.7% 84.4%
Total Operating Cost 907.0M 971.0M 825.0M 657.0M 561.0M 335.0M 371.0M 172.0M 86.2M 57.6M
Selling Expenses 547.0M 494.0M 428.0M 412.0M 371.0M 217.0M 249.0M 111.0M 30.0M 12.5M
Admin Expenses 111.0M 107.0M 82.7M 86.3M 73.9M 57.7M 61.5M 23.5M 19.5M 14.7M
Rd Expenses 132.0M 253.0M 180.0M 78.9M 58.3M 22.8M 18.9M 4.3M 6.4M 5.0M
Finance Expenses -8.6M -7.9M -11.0M -21.1M -12.1M -173,000 159,300 4.8M 9.7M 11.1M
+Operating Income 467.0M 577.0M 686.0M 916.0M 485.0M 223.0M 190.0M 90.9M 6.7M 13.5M
Operating Margin % 32.6% 36.6% 47.4% 70.9% 46.7% 40.2% 34.0% 34.7% 7.2% 19.0%
Non Operating Income 6,300 15,500 122,500 421,000 5,300 5,000 37,700 56,500 422,100 1.4M
Non Operating Expenses 266,600 2.6M 1.8M 599,600 1.1M 76,200 242,900 86,300 37,400 11,700
Investment Income 891,200 348,800 5.0M 4.7M 2.2M -- -- -- -- --
Fair Value Change Income -59.7M -31.6M 51.9M 269.0M -- -- -- -- -- --
Asset Disposal Income -1.8M -186,800 -- -- -98,900 53,700 -3,200 30,400 -- --
Asset Impairment Loss 1.6M 1.6M 8.7M 2.0M -34,400 2.1M 7.0M -900,200 11.3M 2.9M
Other Income 3.0M 1.4M 7.1M 6.8M 5.0M 3.6M 716,500 799,200 -- --
Income Before Tax 467.0M 574.0M 684.0M 916.0M 484.0M 223.0M 189.0M 90.9M 7.1M 14.9M
Income Tax 68.4M 64.8M 85.7M 86.1M 75.9M 36.6M 35.3M 16.4M 460,700 3.2M
+Net Income 399.0M 509.0M 598.0M 829.0M 408.0M 187.0M 154.0M 74.5M 6.7M 11.7M
Net Margin % 27.9% 32.3% 41.3% 64.2% 39.3% 33.7% 27.5% 28.4% 7.2% 16.5%
Net Income Attributable 399.0M 509.0M 598.0M 829.0M 408.0M 187.0M 154.0M 74.5M 6.7M 11.7M
Eps Basic 3.03 3.81 4.47 6.16 5.18 4.15 3.46 -- -- --
Eps Diluted 3.03 3.81 4.46 6.16 5.18 4.15 3.46 -- -- --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015
Cash And Equivalents 1.0B 1.0B 651.0M 927.0M 1.1B 242.0M 92.4M 62.6M 9.8M 9.1M
Trading Financial Assets -- -- -- -- 180.0M -- -- -- -- --
Accounts Receivable 1.3B 1.4B 1.3B 837.0M 353.0M 276.0M 251.0M 105.0M -- --
Notes Receivable -- -- -- -- -- -- -- 909,300 -- --
Notes And Accounts Receivable 1.3B 1.4B 1.3B 837.0M 353.0M 276.0M 251.0M 106.0M 70.9M 30.1M
Prepayments 9.9M 17.1M 35.2M 70.3M 28.8M 10.1M 9.8M 1.7M 615,300 1.9M
Inventory 177.0M 174.0M 154.0M 105.0M 49.9M 48.6M 38.6M 37.9M 35.4M 36.7M
Total Current Assets 2.5B 2.7B 2.1B 1.9B 1.8B 577.0M 392.0M 209.0M 125.0M 87.2M
Long Term Equity Investment 6.4M 6.5M -- -- -- -- -- -- -- --
Fixed Assets -- 849.0M 462.0M 249.0M 74.4M 77.6M 53.3M 50.8M -- --
Fixed Assets Total 956.0M 849.0M 462.0M 249.0M 74.4M 77.6M 53.3M 50.8M 54.5M 60.0M
Construction In Progress -- 112.0M 523.0M 239.0M 128.0M 2.3M 27.8M -- -- --
Construction In Progress Total 3.0M 112.0M 523.0M 239.0M 128.0M 2.3M 27.8M -- -- --
Intangible Assets 17.5M 15.4M 17.2M 18.8M 21.8M 9.1M 11.6M 13.2M 15.3M 17.5M
Long Term Deferred Expenses 143.0M 94.4M 53.8M 36.1M 25.1M 18.9M -- -- -- --
Total Non Current Assets 1.5B 1.6B 1.6B 1.1B 368.0M 112.0M 93.7M 65.5M 75.5M 82.6M
Total Assets 4.0B 4.2B 3.7B 3.0B 2.1B 689.0M 486.0M 275.0M 201.0M 170.0M
Short Term Borrowings 187.0M 191.0M 109.0M -- -- 10.0M 19.0M 7.5M -- --
Accounts Payable 5.0M 3.1M 16.3M 6.1M 5.9M 3.5M 2.5M 705,800 -- --
Advance Receipts -- -- -- -- -- 25,000 25,500 23,400 141,600 2.4M
Contract Liabilities 1.0M 295,500 234,000 -- -- -- -- -- -- --
Total Current Liabilities 566.0M 682.0M 612.0M 339.0M 170.0M 113.0M 117.0M 85.6M 297.0M 272.0M
Long Term Borrowings -- -- 15.7M -- -- -- -- -- -- --
Total Non Current Liabilities 13.7M 13.5M 23.7M 8.8M 2.9M 1.4M 1.6M 818,500 325,300 182,800
Total Liabilities 580.0M 695.0M 635.0M 348.0M 173.0M 114.0M 118.0M 86.4M 297.0M 273.0M
Paid In Capital 133.0M 135.0M 135.0M 90.0M 60.0M 45.0M 45.0M 14.9M 10.0M 10.0M
Capital Reserve 1.1B 1.2B 1.2B 1.2B 1.2B 261.0M 241.0M 205.0M -- --
Surplus Reserve 67.3M 67.3M 67.3M 45.0M 30.0M 26.9M 8.2M -- -- --
Retained Earnings 2.4B 2.3B 1.8B 1.4B 647.0M 242.0M 73.9M -31.8M -106.0M -113.0M
Equity Attributable 3.4B 3.5B 3.1B 2.7B 2.0B 575.0M 368.0M 188.0M -96.2M -103.0M
Total Equity 3.4B 3.5B 3.1B 2.7B 2.0B 575.0M 368.0M 188.0M -96.2M -103.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015
Cash From Sales 1.5B 1.5B 1.0B 839.0M 994.0M 546.0M 429.0M 234.0M 49.3M 61.8M
Total Operating Cash Inflow 1.6B 1.5B 1.0B 869.0M 1.0B 551.0M 444.0M 262.0M 56.4M 66.4M
Cash Paid For Goods 28.9M 89.1M 65.3M 120.0M 32.7M 33.9M 35.3M 24.5M 5.0M 9.0M
Cash Paid To Employees 172.0M 150.0M 134.0M 104.0M 69.7M 50.1M 44.2M 22.6M 19.0M 18.8M
Taxes Paid 144.0M 105.0M 144.0M 119.0M 116.0M 48.4M 48.0M 17.3M 3.4M 3.2M
Total Operating Cash Outflow 1.0B 940.0M 834.0M 739.0M 646.0M 368.0M 387.0M 172.0M 53.8M 59.9M
Operating Cash Flow 572.0M 574.0M 195.0M 130.0M 370.0M 183.0M 57.4M 90.0M 2.6M 6.5M
Total Investing Cash Inflow 102.0M 50.4M 217.0M 964.0M 287.0M 66,100 3,922 148,100 -- --
Total Investing Cash Outflow 444.0M 214.0M 629.0M 1.2B 728.0M 24.0M 34.6M 4.5M 1.9M 3.1M
Investing Cash Flow -342.0M -163.0M -412.0M -202.0M -441.0M -24.0M -34.6M -4.4M -1.9M -3.1M
Cash From Borrowings 238.0M 222.0M 156.0M -- -- 23.5M 19.0M 7.5M -- --
Dividends And Interest Paid 268.0M 71.6M 137.0M 90.0M 230,800 532,800 5.9M 21.3M -- --
Debt Repayments 242.0M 157.0M 30.0M -- 10.0M 32.5M 7.5M 229.0M -- --
Total Financing Cash Inflow 238.0M 222.0M 161.0M -- 997.0M 23.5M 20.4M 218.0M -- --
Total Financing Cash Outflow 710.0M 229.0M 235.0M 147.0M 20.8M 33.0M 13.4M 250.0M -- --
Financing Cash Flow -472.0M -7.1M -73.6M -147.0M 976.0M -9.5M 7.0M -32.8M -- --
Net Change In Cash -240.0M 403.0M -291.0M -219.0M 904.0M 149.0M 29.8M 52.7M 795,900 3.4M
Ending Cash Balance 800.0M 1.0B 636.0M 927.0M 1.1B 242.0M 92.4M 62.6M 9.8M 9.1M
Capex 144.0M 157.0M 419.0M 315.0M 136.0M 24.0M 34.6M 4.5M 1.9M 3.1M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...